The invention generally relates to devices and methods for treating cardiac tissue, including percutaneous closure of cardiac openings such as a patent foramen ovale (PFO) and obliteration of the cardiac cul-de-sacs. The invention includes a device having at least one elongated member. The elongated member has a first material and a second material interwoven with at least a portion of the first material. The second material is capable of transferring energy to tissue in need of treatment.

Patent
   9259267
Priority
Sep 06 2005
Filed
Sep 06 2006
Issued
Feb 16 2016
Expiry
Dec 17 2029
Extension
1198 days
Assg.orig
Entity
Large
2
325
currently ok
1. A device for treating cardiac tissue, comprising:
a first sheath comprising a distal end, a proximal end and a lumen extending between the distal end and proximal end of the sheath;
an elongated member slidably disposed within the lumen of the first sheath, the elongated member having two ends both affixed at a proximal end to form a closed loop having a hairpin turn at a distal end, wherein the elongated member is adapted to unfurl from the lumen of the first sheath by advancing one affixed end of the elongated member toward the distal end of the elongated member thereby advancing the hairpin turn beyond the distal end of the first sheath, the elongated member further comprising a first substantially non-conductive material, and a second energy transferring material at a portion of the elongated member, wherein when the elongated member is unfurled from the lumen of the first sheath, the portion of the elongated member with the second energy transferring material forms the hairpin turn extending beyond the distal end of the first sheath; and
an actuator operatively joined to the proximal end of the elongated member, wherein when the elongated member is unfurled and the device is actuated, the second energy transferring material is rotated about the hairpin turn.
2. The device of claim 1 wherein movement of the actuator causes the elongated member to unfurl from the lumen of the first sheath.
3. The device of claim 2 wherein extension of the elongated member in the distal direction places at least a portion of the second energy transferring material in contact with the cardiac tissue in need of treatment.
4. The device of claim 1 wherein the second energy transferring material comprises a metal selected from the group consisting of copper, gold, platinum, silver, iron, lithium, cobalt, nickel, and chromium, or a combination thereof.
5. The device of claim 1 where in the second energy transferring material comprises an energy transferring ceramic or glass material.
6. The device of claim 1 wherein the second energy transferring material is adapted to transfers energy selected from the group consisting of microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, and cosmic ray.
7. The device of claim 1 wherein the second energy transferring material is adapted to transfer radio frequency energy.
8. The device of claim 1 wherein the second energy transferring material is selected from the group consisting of a thread, filament, cord, rope, ribbon and sheet.
9. The device of claim 1 wherein at least a portion of the elongated member comprises a straight wire or bristles.
10. The device of claim 1 wherein the second energy transforming material comprises a filament.
11. The device of claim 1 wherein at least a portion of the elongated member comprises a sleeve.
12. The device of claim 1 wherein at least a portion of the elongated member comprises a braid, coil, knot, spiral or zigzag.
13. The device of claim 1 wherein at least a portion of the elongated member comprises a tube or a cone.
14. The device of claim 1 wherein the elongated member comprises a lumen.
15. The device of claim 1 wherein movement of the actuator causes movement of the elongated member in an axial direction in relation to the first sheath.
16. The device of claim 1 wherein at least one end of the elongated member is affixed to the actuator.
17. The device of claim 1 wherein movement of the actuator causes the elongated member to retract inside the lumen of the first sheath.
18. The device of claim 1 wherein the elongated member forms a closed loop wherein the two ends of the single wire joined to each other at the proximal end of said elongated member.
19. The device of claim 1 wherein at least a portion of the elongated member comprises a single wire.
20. The device of claim 1 wherein at least a portion of the second energy transferring material is interwoven with at least a portion of the first substantially non-conductive material.

This application claims benefit of and priority to U.S. provisional application 60/714,374, filed Sep. 6, 2005 and U.S. provisional application 60/734,558, filed Nov. 8, 2005, the disclosures of each are incorporated by reference herein.

The invention generally relates to devices and related methods for treating cardiac tissue. More particularly, the invention features devices and methods of using devices comprising at least two different interwoven materials wherein at least one of the materials is an energy transferring material.

The human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by a muscular wall, the interatrial septum, while the ventricles are separated by the interventricular septum.

Either congenitally or by acquisition, abnormal openings, holes, or shunts can occur between the chambers of the heart or the great vessels, causing blood to inappropriately flow there through. Such deformities are usually congenital and originate during fetal life when the heart forms from a folded tube into a four chambered, two-unit system. The septal deformities result from the incomplete formation of the septum, or muscular wall, between the chambers of the heart and can cause significant morbidity.

One such septal deformity or defect, a patent foramen ovale (PFO), is a persistent, one-way, usually tunnel shaped, flap-like opening in the wall between the right atrium and left atrium of the heart. Since left atrial pressure is normally higher than right atrial pressure, the flap typically stays closed. Under certain conditions, however, right atrial pressure exceeds left atrial pressure, creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. This is particularly problematic for patients who are prone to forming venous thrombi, such as those with deep vein thrombosis or clotting abnormalities. Patients with a PFO may be prone to a cerebrovascular accident known as a stroke.

Moreover, certain patients are prone to atrial arrhythmias (i.e., abnormal heart rhythms which can cause the heart to pump less effectively). In a common such abnormality, atrial fibrillation, the two upper chambers of the heart (i.e., the left atria and the right atria), quiver instead of beating in coordination with other cardiac chambers. Because the atria do not beat and empty cleanly during atrial fibrillation, blood can stagnate on the walls and form clots that can then pass through the heart and into the brain, causing a stroke or a transient ischemic attack. These clots typically form in a cul-de-sac in the heart called the left atrial appendage due to its tendency to have low or stagnant flow.

Nonsurgical (i.e., percutaneous) tissue treatment and closure of a patent foramen ovale and similar cardiac openings, such as an atrial septal defect or a ventricular septal defect, as well as obliteration of a left atrial appendage, can be achieved using a variety of mechanical devices that are introduced via an artery into a large peripheral vessel, e.g., the femoral vein. These devices typically consist of a structural framework with a scaffold material attached thereto. Currently available devices, however, are often complex to manufacture, are inconsistent in performance, require a technically complex implantation procedure, lack anatomic conformability, and lead to complications (e.g., thrombus formation, chronic inflammation, residual leaks, perforations, device fractures, and conduction system disturbances).

Improved devices, systems, and related methods for treating cardiac tissue and/or closing cardiac openings, such as, for example, a patent foramen ovale, and for obliterating cardiac cul-de-sacs, such as, for example, a left atrial appendage, are therefore needed.

The present invention provides devices and related methods for treating cardiac tissue. In one aspect, the invention features a device for treating cardiac tissue. The device comprises a first sheath comprising a distal end, a proximal end and a lumen extending between the distal end and proximal end of the sheath. At least one elongated member is slidably disposed within the lumen of the sheath, and the elongated member is comprised of a first material and a second material. The first material is substantially non-conductive, while the second material is an energy transferring material. At least a portion of the second material is interwoven with at least a portion of the first material.

In one embodiment, the second material comprises copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium or a combination thereof, while in another embodiment the second material comprises an energy transferring ceramic or glass material. In another embodiment according to this aspect of the invention, the energy to be transferred includes electromagnetic energy, such as, for example, microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In a further embodiment, the electromagnetic energy comprises radio frequency energy.

According to one embodiment, at least a portion of the elongated member comprises a straight wire or bristles, while in another embodiment, the second material is disposed on a filament. In another embodiment, at least a portion of the elongated member comprises a sleeve, and in an additional embodiment, at least a portion of the elongated member comprises a braid, coil, knot, spiral or zigzag. Alternatively, in yet another embodiment, at least a portion of the elongated member comprises a tube or a cone. In further embodiments, the elongated member comprises a lumen, and a negative force such as a negative pressure or vacuum is applied to the lumen of the elongated member. In other embodiments of the invention, a negative force is applied to the lumen of the sheath, while in a further embodiment the sheath is joined to a vacuum source.

In one embodiment, the device comprises a second sheath comprising a lumen for slidably receiving the first sheath. In additional embodiments, a negative pressure such as a vacuum is applied to the second sheath. In another embodiment, the second sheath is joined to a vacuum source. In a further embodiment, the second sheath is axially disposed within the lumen of the first sheath. In an even further embodiment, the elongated member is slidably receivable within the second sheath, while in another embodiment, the second sheath is axially disposed within a lumen of the elongated member.

In another embodiment of the invention, the elongated member is operatively joined to an actuator. In one embodiment, movement of the actuator causes movement of the elongated member in an axial direction in relation to the sheath. In other embodiments, the sheath is operatively joined to an actuator.

In another embodiment, the elongated member comprises a distal end and a proximal end. In a further embodiment, the elongated member comprises a wire. The wire comprises an open ended loop, the loop comprising a hairpin turn, for example, at the distal end of the elongated member and two free ends at the proximal end of the elongated member. According to one embodiment, at least one free end of the wire is affixed to an actuator. In another embodiment, movement of the actuator in a distal direction unfurls a portion of the elongated member from the lumen of the sheath moving the distal end of the elongated member even further in the distal direction. In a further embodiment, movement of the elongated member in the distal direction places at least a portion of the second material in contact with the cardiac tissue in need of treatment. In yet a further embodiment, movement of the actuator in a proximal direction retracts a portion of the elongated member inside the lumen of the sheath and moves the distal end of the elongated member in the proximal direction.

In another embodiment of the invention, the elongated member comprises a sleeve comprising an exterior surface and an interior surface. In one embodiment, the exterior surface of the sleeve is affixed to an actuator. In a particular embodiment, the sleeve comprises a first position in which a portion of the elongated member comprising the second material interwoven with the first material is located on the interior surface of the sleeve. In a further embodiment, movement of the actuator in a proximal direction transitions the sleeve into a second position wherein at least a portion the interwoven second material is located on the exterior surface of the sleeve.

Another embodiment of the invention features the interior surface of the sleeve affixed to an actuator. According to one embodiment, the sleeve comprises a first position in which the portion of the elongated member comprising the second material interwoven with the first material is located on the exterior surface of the sleeve. In another embodiment, movement of the actuator in a proximal direction transitions the sleeve into a second position wherein at least a portion the interwoven second material is located on the interior surface of the sleeve.

A further aspect of the invention includes a device for treating cardiac tissue. The device comprises at least one elongated member including a first material and a second material. The first material is a substantially non-conductive material, while the second material is an energy transferring material and at least a portion of the second material is interwoven with at least a portion of the first material. In one embodiment, the second material comprises copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium, or a combination thereof. In another embodiment, the second material comprises a glass or ceramic material.

Another aspect of the invention features a method for treating cardiac tissue. The method comprises the step of advancing a device to a position adjacent to cardiac tissue that is in need of treatment. The device includes a first sheath and at least one elongated member slidably disposed within a lumen of the sheath, the elongated member comprising a first material and a second material. The first material is substantially a non-conductive material. At least a portion of the second material is interwoven with at least a portion of the first material. The second material is capable of transferring energy from an energy source. The method further comprises the steps of advancing the elongated member through the lumen of the sheath wherein at least a portion of the second material comes into contact with the cardiac tissue in need of treatment, and applying the energy source to the second material to transfer energy to the cardiac tissue.

In one embodiment of this method of the invention, the elongated member comprises a wire, having an open ended loop. The loop comprises a hairpin turn at a distal end of the elongated member and two free ends at a proximal end of the elongated member. In another embodiment, at least one free end of the wire open-ended loop is operatively joined to an actuator. In a particular embodiment, movement of the actuator in the distal direction unfurls a portion of the elongated member from the lumen of the sheath, thereby moving the distal end of the elongated member in the distal direction. In an additional embodiment, the method further comprises the step of moving the actuator in the distal direction to place at least a portion of the second material in contact with the cardiac tissue in need of treatment. In a further embodiment, movement of the actuator in the proximal direction retracts a portion of the elongated member within the lumen of the sheath and moves the distal end of the elongated member in the proximal direction.

According to one embodiment, energy comprises microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In another embodiment, the energy comprises radio frequency energy.

A further embodiment according to this aspect of the method of the invention comprises the step of attaching a vacuum source in communication with the lumen of the first sheath or the second sheath. The method of the invention can further comprise the step of applying a negative pressure to the lumen of the first sheath or the second sheath. In a further embodiment, the negative pressure is provided by a vacuum generating source, e.g., a pump.

In an additional embodiment, the device of the invention comprises a second sheath having a lumen wherein the first sheath is axially disposed within the second sheath. In one embodiment, the method comprises the step of applying a negative force, e.g., negative pressure to the lumen of the second sheath. In a further embodiment, the device comprises a second sheath having a lumen and the second sheath is axially disposed within the lumen of the first sheath. In a further embodiment, the elongated member is slidably receivable in the second sheath. Alternatively, the elongated member is fixed and the sheath is slideably moveable over the elongated member.

A further aspect of the invention features a method for treating cardiac tissue and comprises the step of advancing a device to a position adjacent to cardiac tissue in need of treatment. The device includes at least one elongated member comprising a first material and a second material. The first material is a substantially non-conductive material. The second material is an energy transferring material. At least a portion of the second material is interwoven with at least a portion of the first material, and the second material is capable of transferring energy from an energy source. This aspect also includes the steps of contacting at least a portion of the second material with the cardiac tissue in need of treatment, and transferring energy to the cardiac tissue in need of treatment.

In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention.

FIG. 1A is a schematic side view of a device for treating cardiac tissue, according to an illustrative embodiment of the invention.

FIG. 1B is a schematic side view of a device for treating cardiac tissue including a vacuum source and vacuum cone according to another embodiment of the invention.

FIG. 1C is a schematic view of a cross section in FIG. 1A taken at 1B-1B.

FIG. 2A is a partial cross-sectional view of a distal end of a device for treating cardiac tissue, the device comprising an elongated member retracted within a lumen of the sheath of the device, according to an illustrative embodiment of the invention.

FIG. 2B is a partial cross-sectional view of the distal end of a device for treating cardiac tissue as illustrated in FIG. 2A, with the elongated member unfurled beyond the distal end of the sheath, according to an illustrative embodiment of the invention.

FIG. 2C is a partial cross-sectional view of the distal end of the device for treating cardiac tissue as illustrated in FIG. 2A, with the elongated member extended distally beyond the lumen of the sheath and in proximity to tissue in need of treatment, according to an illustrative embodiment of the invention.

FIG. 2D is a schematic view of a cross section in FIG. 2C taken at 2D-2D.

FIG. 3A is a partial cross-sectional view of a distal end and proximal end of a device for treating cardiac tissue, the device comprising an elongated member in the form of a sleeve and a cable for manipulating the elongated member, according to an illustrative embodiment of the invention.

FIG. 3B is a schematic view of a cross section in FIG. 3A taken at 3B-3B.

FIG. 3C is a partial cross-sectional view of the device illustrated in FIG. 3A after the elongated member is manipulated in the direction indicated by direction arrow 112 in FIG. 3A, according to an illustrative embodiment of the invention.

FIG. 3D is a schematic view of a cross section in FIG. 3C taken at 3D-3D.

FIG. 4 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising a first sheath, an elongated member and a second sheath surrounding the first sheath, according to an illustrative embodiment of the invention.

FIG. 5 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising a first sheath, an elongated member and a second sheath within the lumen of the first sheath, according to an illustrative embodiment of the invention.

FIG. 6 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising an elongated member having a first material and a second material interwoven with a portion of the first material, according to an illustrative embodiment of the invention.

The present invention features devices and related methods for treating cardiac tissue. The cardiac tissue in need of treatment includes, for example, cardiac septa and tissue of the left and right atria. The invention is also useful in closing various cardiac openings, for example, a patent foramen ovale (PFO), an atrial septal defect, or a ventricular septal defect.

The present invention features systems and related methods for closing cardiac openings, such as, for example, a PFO, described below. Throughout the description, the terms proximal and distal refer to the position of elements relative to the operator of the exemplary apparatus. Proximal is that portion of the device closer to the operator and distal is that portion of the device further away from the operator.

FIG. 1A is a schematic side view of an exemplary device 2 for treating cardiac tissue 18, the device 2 comprising a sheath 4 having a distal end 6, a proximal end 8, and a lumen 10 that extends between the distal end 6 and proximal end 8 of the sheath 4, a handle 30, and an actuator 32 on the handle 30. The exemplary sheath 4 extends from a proximal end 8 at the handle 30 to a distal end 6. In one embodiment, shown in FIG. 1A, the device 2 further features at least one elongated member 12 slidably disposed within the lumen 10 of the sheath 4.

FIG. 1B illustrates yet another embodiment of the device 2 including a vacuum source 102. This embodiment may feature a cone 106 disposed at the distal end 6 of the sheath 4.

The vacuum source 102 is used to apply negative pressure through the vacuum cone 106 to stabilize the sheath 4 while delivering the elongated member 12 into, for example, a PFO tunnel. The vacuum applied to stabilize the sheath 4 may also have the advantage of collapsing the tunnel of the PFO. The lumen 128 of the vacuum cone 106 may be in communication with the lumen 10 of the sheath 4.

A cone, as used herein, means any tubular shape or any tubular shape with a flared end. In a preferred embodiment, the cone 106 includes a tube having a flared end, i.e., the diameter of the distal end 96 of the cone 106 is greater than the diameter of the proximal end 132 of the cone 106. The flare may begin at the proximal end 132 of the cone 106 and extend gradually to the distal end of the cone 106 as illustrated in FIG. 1B, or, alternatively, the flare may begin anywhere along the long axis of the cone 106 and extend to the distal end of the cone 106 (not shown). The distal end of the cone 106 may be circular, oval, U-shaped or any other shape suitable for interfacing with intracardiac tissue. According to the invention, the cone 106 and vacuum source 102 may or may not be present and the invention is not limited to an apparatus including a vacuum or other source of negative pressure. Furthermore, the cone 106 may be applied to the distal end of any sheath in the device and is not limited to the sheath illustrated.

With continued reference to FIG. 1B, in one embodiment, the cone 106 includes a single lumen 128 extending from the proximal end 132 of the cone 106 to the distal end of the cone 106. The lumen 128 of the cone 106 houses the elongated member 12 and may be in communication with the lumen 10 of the sheath 4. In one embodiment, the lumen 128 is in fluid communication with the lumen 10 of the sheath 4. Alternatively, the cone 106 has a plurality of lumens 128 (not shown). One of the plurality of lumens 128 houses the elongated member 12. At least one other of the plurality of lumens 128 is in fluid communication with the lumen 10 of the sheath 4.

Referring still to FIG. 1B, in a preferred embodiment, a vacuum source 102 is operatively joined to the lumen 10 of the sheath 4 to the lumen 128 of the cone 106.

With further reference to FIG. 1B, the elongated member 12 extends through the lumen 10 of sheath 4. In one embodiment, the distal end 33 of the elongated member 12 transitions from a first position, where the distal end 33 of the elongated member 12 is housed within the lumen 10 to a second position, where the distal end 33 of the elongated member 12 is positioned beyond the distal end of the sheath 4 or the distal end of the cone 106 in embodiments including a cone 106.

According to one embodiment of the invention, the elongated member 12 includes a first material 14 and a second material 16. In one embodiment, at least a portion of the second material 16 is interwoven with at least a portion of the first material 14. In a particular embodiment, at least the second material 16 interwoven with first material 14 is an energy transferring material that can transfer energy from an energy source 34 to, for example, adjacent cardiac tissue. The second material 16 may be in the form of a thread, filament cord, rope, ribbon, plate or sheet, for example. In yet another embodiment, the elongated member 12 is transitioned from within the sheath 4 to extend beyond the distal end 6 of the sheath 4 to place the distal end of the elongated member 12 including the second material 16 in direct contact or, alternatively in indirect contact, for example, through water or saline, with cardiac tissue 18 in need of treatment.

The elongated member 12 can be any shape depending on the intended use of the device 2 and/or the user's preference. In certain embodiments, the elongated member 12 comprises a straight wire or, alternatively, one or more bristles (not shown) at the distal end 33 of the elongated member 12. In another embodiment, the elongated member 12 comprises a sleeve. In other embodiments, the elongated member 12 comprises a braid, coil, knot, spiral or zigzag shape. Alternatively, the elongated member 12 can be in the shape of a tube or a cone. In certain embodiments, the elongated member 12 includes a lumen. In other embodiments, the device of the invention comprises two or more elongated members 12. Each elongated member 12 can be manipulated independently or in unison with the other(s) in the manner described below.

In a particular embodiment, the second material 16 may be positioned on one or more bristles or braided, coiled, knotted, spiral or zig zag or bonded with the first material 14 on the elongated member 12. For example, the first material 14 may be an insulator of the second material 16. Uninsulated portions of the second material 16 are contacted with the tissue in need of treatment. Alternatively, the elongated member 12 may include only the second material 16.

With respect to the material of the elongated member 12, by “interwoven” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are connected closely by being in direct contact with each other, e.g., threaded, woven through or overlapping the other or indirect contact. By “direct contact” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are physically touching each other. By “indirect contact” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are in physical contact with a common object or common third material. By “threaded” it is meant that one material in the form of a thread or wire is physically passed into or through the other.

In one embodiment according to the invention, the first material 14 and the second material 16 of the elongated member are different compositions. According to one embodiment, the first material 14 comprises, for example, a polymer, such as a plastic, for example, nylon or polyester. The second material 16 comprises any material capable of transferring energy, for example, electromagnetic energy, from an energy source to a target tissue, for example, cardiac tissue. In one embodiment, the second material is, for example, copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium, glass, ceramic or a combination thereof. The electromagnetic energy transferred may be, for example, one of microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, laser energy, or cosmic ray. In a particular embodiment, the electromagnetic energy is radio frequency energy.

According to one embodiment of the invention, at least a portion of the second material 16 is interwoven with at least portion of the first material 14. For example, the materials 14, 16 can cross each other one or more times, be braided together, threaded through one another, twisted together, coiled together, woven through each other, and/or knotted together. Alternatively, the materials 14, 16, when placed adjacent to each other, can be collectively formed into the shape of a braid, coil, knot, spiral, zigzag, straight wire, or bristles. The material 14, 16 may be laminated or crimped together. The second material 16 extends from the energy source 34 to at least the distal end of the elongated member 12.

Referring now to FIG. 1A, another embodiment of the invention features the sheath 4 operatively joined to an actuator 32, positioned on, for example, a handle 30, wherein movement of the actuator 32 causes axial movement of the sheath 4 relative to the stationary elongated member 12. In another embodiment, the elongated member 12 is operatively joined to the actuator 32 wherein movement of the actuator causes axial movement of the elongated member 12 relative to the stationary sheath 4. In one embodiment, the actuator is a knob or a button.

FIG. 1C is a schematic view of a cross section in FIG. 1A taken at 1C-1C. As shown in FIG. 1C, one embodiment of the invention features the elongated member 12 located within the lumen 10 of the sheath 4.

FIG. 2A is a partial cross-sectional view of a distal end of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 retracted within a lumen 10 of the device 2 according to an illustrative embodiment of the invention. As shown in FIG. 2A, one embodiment features an elongated member 12 comprising a distal end 33 and a proximal end 50. According to the illustrative embodiment, the elongated member 12 is, for example, a single wire such as for example, a single braided wire comprising a hairpin turn 36 at the distal end 33 of the elongated member 12 to form an open loop configuration with the two free ends 52 of the wire located at the proximal end 50 of the elongated member 12. In one embodiment, the elongated member 12 is in the form of a wire that forms a closed loop configuration at the distal end 33 of the elongated member 12, with both of the ends 52 of the wire joined to each other or joined to a common object, for example, directly or indirectly to an actuator, at the proximal end 50 of the elongated member 12.

In one embodiment, the second material 16 follows the path of the first material 14 forming a bipolar device. Alternatively, the second material 16 partially follows the path of the first material 14, forming a unipolar device.

With continued reference to the embodiment shown in FIG. 2A, at least one end 52 of the wire is operatively joined to an object, for example, a carrying cable 20. According to one embodiment, the carrying cable 20 is connected to an actuator (not shown) such that actuation of the actuator effectuates movement of the cable 20 and the elongated member 12. In a particular embodiment, movement of the actuator causes the elongated member 12 to move axially in relation to the sheath 4, i.e., in a motion-parallel to the sheath 4 (as indicated by direction arrows 100 and 102). In another embodiment, movement of the actuator causes the elongated member 12 to move in a circumferential motion, i.e., rotational movement of the circumference of the loop in one or more directions as indicated by arrows 108 and 110.

In a further embodiment, the one end 52 of the wire that is not joined to the cable 20 is fixed within the device 2. In another embodiment, as shown in FIG. 2B, axial movement of the cable 20 in the distal direction allows the elongated member 12 to unfurl from the lumen 10 of the sheath 4. By unfurl it is meant that the distal end portion 46 of the elongated member 12 moves in the distal direction to extend the length of the elongated member 12 from the proximal end 50 to the distal end 33 of the elongated member 12 while the end 52 remains stationary (similar to that of a bicycle chain, for example, with one end fixed) as indicated by direction arrows 104 and 106 in FIG. 2A, relative to the sheath 4. The distal end 33 of the unfurled elongated member 12 can be extended beyond the distal end 6 of the sheath 4. Alternatively, axial movement of the cable 20 in the proximal direction can allow the distal end 33 of the elongated member 12 to move in the proximal direction and retract the distal end 33 of the elongated member further inside the lumen 10 of the sheath 4.

FIG. 2C is a partial cross-sectional view of the distal end 6 of the device 2 for treating cardiac tissue 18 as illustrated in FIG. 2A, with the elongated member 12 extended distally beyond the lumen 10 of the sheath 4 and in proximity to tissue in need of treatment according to an illustrative embodiment of the invention. As illustrated in FIG. 2C, manipulation of the elongated member 12 according to each of the embodiments described above allows the portion 22 of the elongated member 12 comprising the first interwoven materials 14 and the second interwoven material 16 to be placed in a desired location within a patient's body. Energy is transferred from an energy source 34 to the second material 16 in contact with the target tissue 18 and from the second material 16 to the target tissue 18.

In a preferred embodiment, manipulation of the elongated member 12 carries the second material 16 into the PFO tunnel. Upon further manipulation of the elongated member 12, the distal end of the elongated member retracts proximally, and leaves the PFO tunnel, and the second material transfer energy to the septum tissue along the track, and therefore causes the target tissue to fuse together.

FIG. 2D is a schematic view of a cross section in FIG. 2C taken at 2D-2D. As shown in FIG. 2D, according to the exemplary embodiment of FIG. 2C, the elongated member 12, for example, is a wire having a hairpin turn. One end of the wire is attached to the cable 20. The elongated member 12 is axially positioned within the lumen 10 of the sheath 4.

FIG. 3A is a partial cross-sectional view of a distal end portion 38 of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 in the form of a sleeve and a cable 20 for manipulating the elongated member 12 according to an illustrative embodiment of the invention. According to one embodiment, the sleeve 12 comprises an interior surface 42 and an exterior surface 44. In the embodiment shown in FIG. 3A, the portion of the elongated member 12 comprising the second material 16 interwoven with the first material 14 is located at least on the interior surface 42 of the sleeve 12.

FIG. 3B is a schematic view of a cross section in FIG. 3A taken at 3B-3B. In one embodiment, shown in FIG. 3B, the sleeve 12, located within the lumen 10 of the sheath 4, comprises an interior surface 42 and an exterior surface 44, wherein the portion of the sleeve 12 comprising the interwoven second material 16 is located on the interior surface 42 of the sleeve 12.

Referring now to the embodiment shown in FIG. 3A, the portion of the elongated member 12 comprising the second material 16 interwoven with the first material 14 is initially located on the interior surface 42 of the sleeve 12. According to one embodiment, the cable 20 is operatively joined to the exterior surface 44 of the sleeve 12. Referring now to FIG. 3C, axial movement of the cable 20 proximally in the direction indicated by direction arrow 112 lengthens the exterior surface 44 and shortens the interior surface 42 of the sleeve. At least a portion of the inner surface of the sleeve 12 becomes everted and at least a portion of the sleeve 12 comprising the interwoven second material 16 is relocated from the interior surface 42 to the exterior surface 44 of the sleeve 12. In one embodiment for treating cardiac tissue, the portion of the everted sleeve 12 comprising the interwoven second material 16 contacts the tissue in need of treatment when the second material 16 on the distal end of the sleeve 12 is extended beyond the distal end of the sheath 4, and electromagnetic energy from the energy source is transferred from the second material 16 to the tissue.

Alternatively, in another embodiment (not shown), the cable 20 is operatively joined to the interior surface 42 of the sleeve 12. Axial movement of the cable 20 in a distal direction lengthens the exterior surface 44 and shortens the interior surface 42 of the sleeve such that at least a portion of the interior surface 42 of the sleeve 12 becomes everted and at least a portion of the sleeve 12 comprising the interwoven second material 16 is relocated to the distal end of the sleeve 12 and the exterior surface 44 of the inverted sleeve 12. In one embodiment for treating cardiac tissues, the portion of the everted sleeve 12 comprising the interwoven second material 16 contacts the tissue in need of treatment and electromagnetic energy from the energy source is transferred from the second material 16 to the tissue.

FIG. 3D is a schematic view of a cross section in FIG. 3C taken at 3D-3D. In the exemplary embodiment, shown in FIG. 3D, the sleeve 12 is located within the lumen 10 of the sheath 4 and the portion of the sleeve 12 comprising the interwoven second material 16 is located on both the interior surface 42 and the exterior surface 44 of the inverted sleeve 12.

Referring now to FIGS. 3C and 3D, according to one embodiment of the invention, the sheath 4 of the device 2 moves relative to the sleeve 12 such that movement of the sheath 4 in the proximal direction exposes the sleeve 12 beyond the distal end of the sheath 4. In another embodiment, the sleeve 12 moves relative to the sheath 4, such that movement of the sleeve 12 in the distal direction exposes the sleeve 12 beyond the distal end of the sheath 4.

In further embodiments of the invention of the device 2, the proximal end 8 of the sheath 4 is coupled to a vacuum source to allow functional communication with the lumen 10 of the sheath 4. This configuration allows the user to apply negative pressure, i.e., suction, to the targeted cardiac tissue 18 as the distal end of the sheath 4 is applied to the tissue 18. The negative pressure vacuum can be used to draw the cardiac tissue toward the second material 16. With the tissue in contact with the second material 16, energy transfers from the second material 16 directly to the tissue. In one embodiment, the negative pressure from the vacuum source is maintained while the energy is applied to the tissue.

FIG. 4 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device 2 comprising a first sheath 4, an elongated member 12 and a second sheath 24 surrounding the first sheath 4 according to an illustrative embodiment of the invention. The elongated member 12 may be any one of the elongated members illustrated in FIGS. 1A-1C, 2A-2D, or 3A-3D and described in the corresponding text. In one embodiment, as illustrated in FIG. 4, the lumen 26 of second sheath 24 surrounds the first sheath 4 and the first sheath 4 is located within the lumen 26 of the second sheath 24. In another embodiment, the second sheath 24 is functionally joined to a vacuum source, for example, at the proximal end 28 of the second sheath 24.

FIG. 5 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device comprising a first sheath 4, an elongated member 12 and a second sheath 24 within the lumen 10 of the first sheath 4, according to an illustrative embodiment of the invention. In one embodiment, as shown in FIG. 5, the second sheath 24 is axially positioned within the lumen 10 of the first sheath 4 and surrounds the elongated member 12 such that the elongated member 12 is located within the lumen 26 of the second sheath 24. In another embodiment (not shown), the second sheath 24 is within the lumen 10 of the first sheath 4 and adjacent to the elongated member 12. In one embodiment, the second sheath 24 is functionally joined to a vacuum source, at, for example, a proximal end 28 of the second sheath 24. In an even further embodiment (not shown), the elongated member 12 comprises a lumen, and the second sheath 24 functionally joined to the vacuum source is axially positioned within the lumen of the elongated member 12. The elongated member 12 may be any one of the elongated members illustrated in FIGS. 1A-1C, 2A-2D, or 3A-3D and described in the corresponding text.

The first sheath 4 and the second sheath 24 can be any shape suited to its function. For example, the sheath 4 or sheath 24 can be tubular or funnel shape. The sheath 4 or sheath 24 can have a lumen of uniform or variable diameter. For example, the sheath 4 or sheath 24 in a particular embodiment includes a flared distal end. In another embodiment, the sheath 4 or sheath 24 comprises an invertible sleeve.

FIG. 6 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 having a first material 14 and a second material 16 interwoven with a portion of the first material 14, according to an illustrative embodiment of the invention. In one embodiment, the second material 16 of the elongated member 12 is an energy transferring material. The elongated member 12 includes, for example, a flared distal end 30. The portion of the elongated member 12 having at least a portion of the interwoven second material 16 is located on the flared distal end 30. In a further embodiment, the elongated member 12 comprises a uniform fixed diameter. In other embodiments, the elongated member 12 comprises a lumen that is functionally joined to a vacuum source for the application of negative pressure to cardiac tissue.

Another aspect of the invention features a method for treating cardiac tissue. The method comprises the steps of advancing a device 2 according to the invention to a position adjacent to cardiac tissue 18 in need of treatment, the device 2 includes a sheath 4 and at least one elongated member 12 slidably disposed with a lumen 10 of the sheath 4. In one embodiment, the elongated member 12 includes a first material 14 and a second material 16. At least a portion of the second material 16 is interwoven with a portion of the first material 14. As described above with respect to other embodiments, the second material 16 is capable of transferring energy, for example, electromagnetic energy, from an energy source. According to this embodiment, the method comprises the step of advancing the elongated member 12 through the lumen 10 of the sheath. At least a portion of the second material 16 is placed into contact with cardiac tissue in need of treatment 18. The method further includes the step of applying energy from the energy source to the second material 16 to transfer energy to the cardiac tissue 18 in need of treatment.

In one embodiment according to this aspect of the invention, the energy applied to the cardiac tissue includes one of microwave, infrared, visible and ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In another embodiment, the energy is radio frequency energy.

According to a further embodiment of the method of the invention, an operator provides an elongated member 12 including a wire having a hairpin turn 36 at a distal end 33 of the elongated member 12 to form an open ended loop having two ends 52 of the wire at a proximal end of the elongated member 12. At least one end 52 of the wire is operatively joined to an actuator 32. Actuating the actuator 32 in the distal direction unfurls a portion of the elongated member 12 from the lumen 10 of the sheath 4 and moves the distal end 36 of the elongated member 12 in the distal direction. In an additional embodiment, the method further comprises the step of actuating the actuator 32 to move the elongated member 12 distally to place at least a portion of the second material 16 in contact with the cardiac tissue 18 in need of treatment. In a further embodiment, actuating the actuator 32 to move the elongated member 12 in the proximal direction retracts a portion of the elongated member 12 within the lumen 10 of the sheath 4 and moves the distal end 36 of the elongated member 12 in the proximal direction.

A further embodiment of the invention includes an additional step of attaching a vacuum source to the lumen 10 of the sheath 4. According to this embodiment, a vacuum or negative pressure, i.e., suction, is applied to the cardiac tissue 18 to draw the cardiac tissue 18 toward the device 2. In another embodiment, the device 2 comprises a second sheath 24 having a lumen 26, and the method comprises an additional step of attaching a vacuum source to the lumen 26 of the second sheath 24. According to this embodiment, a vacuum can be applied to cardiac tissue to draw the tissue toward the device 2. In both of these embodiments, the cardiac tissue drawn toward the device 2 is contacted with the second material 16 and energy is transferred from the second material 16 to the tissue 18. The vacuum or negative pressure can also be maintained on the tissue while the energy is being applied to the tissue.

A further aspect of the invention includes a method for treating cardiac tissue comprising the step of advancing a device 2 to a position adjacent to cardiac tissue in need of treatment, the device 2 having at least one elongated member 12 comprising a first material 14 and a second material 16. At least a portion of the second material 16 is interwoven with at least a portion of the first material 14. The second material 16 is capable of transferring energy from an energy source to a target tissue, for example, cardiac tissue. The method further comprises the steps of advancing the elongated member 12 through the body of a patient until at least a portion of the second material 16 comes into contact with the cardiac tissue in need of treatment, and applying the energy source to the second material 16 to transfer energy to the cardiac tissue in need of treatment.

In yet another aspect, the invention provides methods for percutaneously closing a PFO using a device 2 such as the device according to the invention depicted in FIGS. 1-6. In one exemplary embodiment, an operator, e.g., a physician, advances the device 2 into the patient's heart with the elongated member 12 retracted within the lumen 10 of the sheath 4. The operator then positions the distal end 6 of the sheath 4 in the right atrium proximate the PFO. With the device 2 positioned as such, the elongated member 12 is deployed into the tunnel of the PFO. As described above, the elongated member 12 is manipulated such that the portion of the elongated member comprising the interwoven second material 16 is exposed to the patient's tissue surface located within the tunnel of the PFO. The second material 16 is connected to an energy source, and energy is transferred from the second material 16 to the tissue surface to close the PFO. The physician then retracts the elongated member 12 from the PFO and removes the device 2 from within the patient.

In a similar embodiment, the device 2 comprising the elongated member 12 is advanced within a patient as described above and is placed adjacent to the right atrial wall of the heart. The elongated member 12 comprises a vacuum which is placed in contact with the right atrial wall, and the portion of the elongated member 12 comprising the interwoven second material 16 is placed in contact with the tissue of the right atrial wall. The vacuum is then activated, attaching the elongated member 12 to the right side of the fossa ovalis. Energy is then delivered to the second material 16 from an energy source, and the energy is transferred from the second material 16 to the fossa ovalis. The energy is absorbed by the surrounding cardiac tissue to close the PFO.

In yet another embodiment of the method according to the invention, the elongated member of the device described herein may be used to delivery energy to the tissues within the tunnel of a PFO as described in co-owned application titled, “In tunnel electrode for sealing intra-cardiac defects”, co-filed on the same date as the instant application and incorporated by reference in its entirety herein.

Variations, modifications, and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. The invention is not to be defined only by the preceding illustrative description.

Forde, Sean

Patent Priority Assignee Title
10368942, Sep 06 2005 W. L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
9844453, Aug 27 2001 Boston Scientific Scimed, Inc. Positioning tools and methods for implanting medical devices
Patent Priority Assignee Title
3874388,
4007743, Oct 20 1975 Baxter International Inc Opening mechanism for umbrella-like intravascular shunt defect closure device
4696300, Apr 11 1985 Dennison Manufacturing Company Fastener for joining materials
4710192, Dec 30 1985 Diaphragm and method for occlusion of the descending thoracic aorta
4832048, Oct 29 1987 CORDIS WEBSTER, INC Suction ablation catheter
4836204, Jul 06 1987 Method for effecting closure of a perforation in the septum of the heart
4902508, Jul 11 1988 METHODIST HOSPITAL OF INDIANA, INC Tissue graft composition
4917089, Aug 29 1988 Buttoned device for the transvenous occlusion of intracardiac defects
4921484, Jul 25 1988 Cordis Corporation Mesh balloon catheter device
4944741, Dec 09 1988 Laproscopic instrument with pivotable support arm
4945912, Nov 25 1988 INNOVATIVE CARDIAC SOLUTIONS, INC Catheter with radiofrequency heating applicator
4946440, Oct 05 1988 Evertible membrane catheter and method of use
4956178, Jul 11 1988 METHODIST HOSPITAL OF INDIANA, INC Tissue graft composition
4967765, Jul 28 1988 AMS Research Corporation Urethral inserted applicator for prostate hyperthermia
5003990, Jul 28 1988 Apparatus for implanting electrodes and the like in animal bodies
5007908, Sep 29 1989 GYRUS ACMI, INC Electrosurgical instrument having needle cutting electrode and spot-coag electrode
5021059, May 07 1990 Kensey Nash Corporation Plug device with pulley for sealing punctures in tissue and methods of use
5025799, May 13 1987 ABBOTT LABORATORIES VASCULAR ENTITLES LIMITED; Abbott Laboratories Vascular Enterprises Limited Steerable memory alloy guide wires
5108420, Feb 01 1991 MARKS, LLOYD A Aperture occlusion device
5156613, Feb 13 1991 Baxter International Inc; BAXTER HEALTHCARE S A Collagen welding rod material for use in tissue welding
5171259, Apr 02 1990 Device for nonoperatively occluding a defect
5176687, May 10 1991 Disposable pouch container for isolation and retrieval of tissues removed at laparoscopy
5217435, Jan 07 1992 Cardiac catheter apparatus
5222974, Nov 08 1991 KENSEY NASH CORPORATION, A CORPORATION OF DELAWARE Hemostatic puncture closure system and method of use
5275826, Nov 13 1992 METHODIST HOSPITAL OF INDIANA, INC Fluidized intestinal submucosa and its use as an injectable tissue graft
5282827, Nov 08 1991 KENSEY NASH CORPORATION, A DE CORP Hemostatic puncture closure system and method of use
5284488, Dec 23 1992 Adjustable devices for the occlusion of cardiac defects
5304184, Oct 19 1992 Indiana Research and Technology Corporation; Indiana University Research and Technology Corporation Apparatus and method for positive closure of an internal tissue membrane opening
5312341, Aug 14 1992 Wayne State University; WAYNE STATE UNIVERSITY, A CORP OF MICHIGAN Retaining apparatus and procedure for transseptal catheterization
5312435, May 17 1993 Kensey Nash Corporation Fail predictable, reinforced anchor for hemostatic puncture closure
5334217, Jan 21 1992 Regents of the University of Minnesota Septal defect closure device
5370644, Nov 25 1988 INNOVATIVE CARDIAC SOLUTIONS, INC Radiofrequency ablation catheter
5385156, Aug 27 1993 Rose Health Care Systems Diagnostic and treatment method for cardiac rupture and apparatus for performing the same
5423882, Dec 26 1991 CORDIS WEBSTER, INC Catheter having electrode with annular recess and method of using same
5425744, Nov 05 1991 CHILDREN S MEDICAL CENTER CORPORATION Occluder for repair of cardiac and vascular defects
5433727, Aug 16 1994 Centering buttoned device for the occlusion of large defects for occluding
5451235, Nov 05 1991 CHILDREN S MEDICAL CENTER CORPORATION Occluder and method for repair of cardiac and vascular defects
5484385, Apr 21 1994 ARROW INTERNATIONAL INVESTMENT CORP Intra-aortic balloon catheter
5486185, Jan 30 1989 Tyco Healthcare Group LP Surgical apparatus
5507744, Apr 23 1992 Boston Scientific Scimed, Inc Apparatus and method for sealing vascular punctures
5507811, Nov 26 1993 Nissho Corporation Prosthetic device for atrial septal defect repair
5540681, Apr 10 1992 Medtronic CardioRhythm Method and system for radiofrequency ablation of tissue
5573533, Apr 10 1992 Medtronic CardioRhythm Method and system for radiofrequency ablation of cardiac tissue
5578045, Jan 21 1992 Regents of the University of Minnesota Septal defect closure device
5597378, Oct 14 1983 Medtronic, Inc Medical devices incorporating SIM alloy elements
5620461, May 29 1989 MEDIFIX R&D BV TE PUTTEN Sealing device
5620479, Nov 13 1992 Regents of the University of California, The Method and apparatus for thermal therapy of tumors
5626599, Jan 22 1992 Medtronic Ave, Inc Method for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
5630837, Jul 01 1993 Boston Scientific Scimed, Inc Acoustic ablation
5634936, Feb 06 1995 Boston Scientific Scimed, Inc Device for closing a septal defect
5636634, Mar 16 1993 EP Technologies, Inc Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes
5649950, Jan 22 1992 Medtronic Ave, Inc System for the percutaneous transluminal front-end loading delivery and retrieval of a prosthetic occluder
5653684, Mar 19 1994 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Catheter with expandable wire mesh tip
5669934, Feb 13 1991 Baxter International Inc; BAXTER HEALTHCARE S A Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets
5676662, Mar 17 1995 ST JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC Ablation catheter
5683411, Apr 06 1994 Cook Medical Technologies LLC Medical article for implantation into the vascular system of a patient
5690675, Feb 13 1991 Baxter International Inc; BAXTER HEALTHCARE S A Methods for sealing of staples and other fasteners in tissue
5702421, Jan 11 1995 Closure device for closing a vascular opening, such as patent ductus arteriosus
5709707, Oct 30 1995 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
5725552, Jul 08 1994 AGA Medical Corporation Percutaneous catheter directed intravascular occlusion devices
5733294, Feb 28 1996 Scion Medical Limited Self expanding cardiovascular occlusion device, method of using and method of making the same
5733337, Apr 07 1995 Organogenesis, Inc Tissue repair fabric
5741249, Nov 25 1996 MAQUET CARDIOVASCULAR LLC Anchoring tip assembly for microwave ablation catheter
5741297, Aug 28 1996 W L GORE & ASSOCIATES, INC Daisy occluder and method for septal defect repair
5749895, Feb 13 1991 Baxter International Inc; BAXTER HEALTHCARE S A Method for bonding or fusion of biological tissue and material
5797905, Aug 08 1994 EP Technologies, Inc Flexible tissue ablation elements for making long lesions
5797907, Nov 06 1989 Mectra Labs, Inc. Electrocautery cutter
5797960, Feb 22 1993 Heartport, Inc Method and apparatus for thoracoscopic intracardiac procedures
5800428, May 16 1996 CORDIS WEBSTER, INC Linear catheter ablation system
5800478, Mar 07 1996 PURDUE PHARMACEUTICAL PRODUCTS L P Flexible microcircuits for internal light therapy
5807384, Dec 20 1996 Eclipse Surgical Technologies, Inc.; Eclipse Surgical Technologies, Inc Transmyocardial revascularization (TMR) enhanced treatment for coronary artery disease
5810810, Apr 30 1993 Boston Scientific Scimed, Inc Apparatus and method for sealing vascular punctures
5810884, May 19 1997 HEART-TECH CORPORATION Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject
5823956, Feb 22 1993 Heartport, Inc. Method and apparatus for thoracoscopic intracardiac procedures
5846261, Jul 08 1994 AGA Medical Corp. Percutaneous catheter directed occlusion devices
5849028, May 16 1997 Irvine Biomedical, Inc. Catheter and method for radiofrequency ablation of cardiac tissue
5853422, Mar 22 1996 Boston Scientific Scimed, Inc Apparatus and method for closing a septal defect
5861003, Oct 23 1996 CLEVELAND CLINIC FOUNDATION, THE Apparatus and method for occluding a defect or aperture within body surface
5865791, Jun 07 1995 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
5879366, Dec 20 1996 W L GORE & ASSOCIATES, INC Self-expanding defect closure device and method of making and using
5893856, Jun 12 1996 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
5895412, Oct 11 1995 Baxter International Inc; BAXTER HEALTHCARE S A Device and method for sealing tissue
5904703, Nov 07 1997 Medtronic Ave, Inc Occluder device formed from an open cell foam material
5919200, Oct 09 1998 Terumo Kabushiki Kaisha Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter
5927284, Sep 20 1995 Medtronic, Inc Method and apparatus for temporarily immobilizing a local area of tissue
5944738, Feb 06 1998 ST JUDE MEDICAL, CARDIOLOGY DIVISION, INC Percutaneous catheter directed constricting occlusion device
5948011, May 15 1995 THERMAGE, INC Method for controlled contraction of collagen tissue via non-continuous energy delivery
5954719, Dec 11 1996 IRVINE BIOMEDICAL, INC System for operating a RF ablation generator
5955110, Apr 07 1995 CLARIAN HEALTH PARTNERS, INC Multilayered submucosal graft constructs and method for making the same
5957919, Jul 02 1997 SRONCUB, INC Bleb reducer
5964782, Sep 18 1997 Boston Scientific Scimed, Inc Closure device and method
5971980, May 02 1995 Cardiac Pacemakers, Inc System for controlling the energy delivered to a patient for ablation
5976174, Dec 15 1997 Medical hole closure device and methods of use
5993844, May 08 1997 Organogenesis, Inc Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
5997575, Apr 05 1996 CLARIAN HEALTH PARTNERS, INC Perforated submucosal tissue graft constructs
6004269, Jul 01 1993 Boston Scientific Scimed, Inc Catheters for imaging, sensing electrical potentials, and ablating tissue
6004316, Oct 30 1996 Terumo Kabushiki Kaisha Method for the treatment of patent ductus arteriosus
6010517, Apr 10 1996 Device for occluding abnormal vessel communications
6015378, Sep 20 1995 Medtronic, Inc Method and apparatus for temporarily immobilizing a local area tissue
6016811, Sep 01 1998 AFX, INC Method of using a microwave ablation catheter with a loop configuration
6024756, Sep 23 1997 Boston Scientific Scimed, Inc Method of reversibly closing a septal defect
6063080, May 16 1996 CORDIS WEBSTER, INC Linear catheter ablation system
6063085, Apr 23 1992 Boston Scientific Scimed, Inc Apparatus and method for sealing vascular punctures
6077291, Jan 21 1992 Regents of the University of Minnesota Septal defect closure device
6080182, Dec 20 1996 W L GORE & ASSOCIATES, INC Self-expanding defect closure device and method of making and using
6086581, Sep 25 1992 EP Technologies, Inc Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
6086610, Oct 22 1996 Cordis Corporation Composite self expanding stent device having a restraining element
6102926, Dec 02 1996 ABBOTT CARDIOVASCULAR SYSTEMS INC Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
6106520, Sep 30 1997 BROWN, TONY R ; LAUFER, MICHAEL D Endocardial device for producing reversible damage to heart tissue
6106532, Apr 06 1998 Nissho Corporation Device for retrieval of defect closure devices
6117159, Mar 22 1996 Boston Scientific Scimed, Inc Apparatus and method for closing a septal defect
6123718, Nov 02 1998 POLYMEREX MEDICAL CORP Balloon catheter
6132438, Jun 07 1995 EP Technologies, Inc Devices for installing stasis reducing means in body tissue
6135997, Sep 26 1996 Covidien LP Method for treating hemorrhoids
6143037, Jun 12 1996 MICHIGAN, REGENTS, THE, UNIVERSITY OF Compositions and methods for coating medical devices
6152144, Nov 06 1998 Boston Scientific Scimed, Inc Method and device for left atrial appendage occlusion
6152918, Apr 05 1996 Eclipse Surgical Technologies, Inc.; Eclipse Surgical Technologies, Inc Laser device with auto-piercing tip for myocardial revascularization procedures
6165183, Jul 15 1998 ST JUDE MEDICAL, INC Mitral and tricuspid valve repair
6171329, Dec 19 1994 W L GORE & ASSOCIATES, INC Self-expanding defect closure device and method of making and using
6174322, Aug 08 1997 Cardia, Inc. Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum
6187039, Dec 10 1996 CLARIAN HEALTH PARTNERS, INC Tubular submucosal graft constructs
6200313, Mar 31 1994 Fuji Photo Optical Co., Ltd. Puncture instrument for punctured high frequency treatments
6206907, May 07 1999 ENCORE MEDICAL INC Occlusion device with stranded wire support arms
6212426, Jul 28 1995 Boston Scientific Scimed, Inc Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
6214029, Apr 26 2000 ev3 Endovascular, Inc Septal defect occluder
6221092, Mar 30 1998 Nipro Corporation Closure device for transcatheter operations and catheter assembly therefor
6231516, Oct 04 1997 Pacesetter, Inc Endoluminal implant with therapeutic and diagnostic capability
6231561, Sep 20 1999 Boston Scientific Scimed, Inc Method and apparatus for closing a body lumen
6238415, Dec 22 1994 STRYKER EUROPEAN HOLDINGS III, LLC Implant delivery assembly with expandable coupling/decoupling mechanism
6251128, Sep 01 1998 AFX, INC Microwave ablation catheter with loop configuration
6270515, Oct 17 1994 Boston Scientific Scimed, Inc Device for closing a septal defect
6283935, Sep 30 1998 LAUFER M D , MICHAEL D Ultrasonic device for providing reversible tissue damage to heart muscle
6287317, Jun 28 1997 Medtronic Vascular, Inc Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
6290674, Sep 20 1999 Boston Scientific Scimed, Inc Method and apparatus for closing intracardiac septal defects
6290699, Jul 07 1999 UAB Research Foundation Ablation tool for forming lesions in body tissue
6292700, Sep 10 1999 ASTORA WOMEN S HEALTH, LLC Endopelvic fascia treatment for incontinence
6306424, Jun 30 1999 ENDO-SURGERY, INC Foam composite for the repair or regeneration of tissue
6312446, Mar 22 1996 Boston Scientific Scimed, Inc Apparatus and method for closing a septal defect
6325798, Feb 19 1998 Mederi RF, LLC; HORIZON CREDIT II LLC Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions
6328727, Sep 20 1999 Boston Scientific Scimed, Inc Transluminal anastomosis method and apparatus
6336926, Jan 15 1999 Gyrus Medical Limited Electrosurgical system
6338726, Feb 06 1997 VIDACARE, INC Treating urinary and other body strictures
6338731, Mar 17 1999 NTERO SURGICAL, INC Method and systems for reducing surgical complications
6352561, Dec 23 1996 W L GORE & ASSOCIATES, INC Implant deployment apparatus
6355052, Feb 09 1996 PFM MEDICAL AG Device for closure of body defect openings
6364853, Sep 11 2000 Conmed Corporation Irrigation and suction valve and method therefor
6364876, Oct 23 1998 MAQUET CARDIOVASCULAR LLC Vacuum-assisted securing apparatus for a microwave ablation instrument
6364878, Jul 07 1999 Cardiac Pacemakers, Inc Percutaneous transluminal ablation catheter manipulation tool
6368340, Apr 03 1995 Clamp assembly and method of use
6375671, Apr 19 1999 Nipro Corporation Closure device for transcatheter operations
6379368, May 13 1999 ENCORE MEDICAL INC Occlusion device with non-thrombogenic properties
6398779, Oct 23 1998 TYCO HEALTHCARE GROUP AG; Covidien AG Vessel sealing system
6402772, May 17 2000 ST JUDE MEDICAL, CARDIOLOGY DIVISION, INC Alignment member for delivering a non-symmetrical device with a predefined orientation
6419669, Sep 20 1999 Boston Scientific Scimed, Inc Method and apparatus for patching a tissue opening
6430446, May 05 1995 Thermage, Inc. Apparatus for tissue remodeling
6432119, Mar 17 1999 ANGIOTRAX, INC Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
6436088, Sep 20 1999 Boston Scientific Scimed, Inc Method and apparatus for closing a subcutaneous tissue opening
6440152, Jul 28 2000 ev3 Endovascular, Inc Defect occluder release assembly and method
6458100, Sep 20 1999 Boston Scientific Scimed, Inc Atrial septal defect closure catheter
6461327, Aug 07 1998 Edwards Lifesciences Corporation Atrial isolator and method of use
6488706, May 08 1996 CARAG AG Device for plugging an opening such as in a wall of a hollow or tubular organ
6494881, Sep 30 1997 Boston Scientific Scimed, Inc Apparatus and method for electrode-surgical tissue removal having a selectively insulated electrode
6503247, Jun 27 1997 ST JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC Process and device for the treatment of atrial arrhythmia
6506189, May 04 1995 Covidien AG; TYCO HEALTHCARE GROUP AG Cool-tip electrode thermosurgery system
6527767, May 20 1998 New England Medical Center Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization
6527786, Apr 09 1998 Origin Medsystems, Inc. System and method of use for ligating and cutting tissue
6540742, Jul 24 1997 Sydney West Area Health Service Intraoperative endocardial and epicardial ablation probe
6544260, Aug 20 1996 Oratec Interventions, Inc Method for treating tissue in arthroscopic environment using precooling and apparatus for same
6551303, Oct 27 1999 Boston Scientific Scimed, Inc Barrier device for ostium of left atrial appendage
6551344, Apr 26 2000 ev3 Endovascular, Inc Septal defect occluder
6558375, Jul 14 2000 CARDIOFOCUS, INC Cardiac ablation instrument
6558385, Sep 22 2000 Medtronic Advanced Energy LLC Fluid-assisted medical device
6582430, Jul 07 1999 Cardiac Pacemakers, Inc. Ablation catheter manipulation tool and method therefor
6596013, Sep 20 2001 Boston Scientific Scimed, Inc Method and apparatus for treating septal defects
6616655, Jun 03 1999 Boston Scientific Scimed, Inc Method and apparatus for performing cardiac ablations
6623508, Dec 20 1996 W L GORE & ASSOCIATES, INC Self-expanding defect closure device and method of making and using
6626901, Mar 05 1997 COLUMBIA, TRUSTEES OF THE UNIVERSITY IN THE CITY OF NEW YORK, THE; TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE Electrothermal instrument for sealing and joining or cutting tissue
6632223, Mar 30 2000 The General Hospital Corporation Pulmonary vein ablation stent and method
6641579, Sep 29 2000 Spectrasonics Imaging, Inc. Apparatus and method for ablating cardiac tissue
6650923, Apr 13 2000 Boston Scientific Scimed, Inc Method for accessing the left atrium of the heart by locating the fossa ovalis
6652517, Apr 25 2000 UAB Research Foundation Ablation catheter, system, and method of use thereof
6656206, May 13 1999 Cardia, Inc. Occlusion device with non-thrombogenic properties
6659105, Apr 03 1998 SenoRx, Inc. Tissue specimen isolating and damaging device and method
6666861, Oct 05 2000 COMEDICUS INC Atrial appendage remodeling device and method
6666863, Mar 01 2001 Boston Scientific Scimed, Inc Device and method for percutaneous myocardial revascularization
6673068, Apr 12 2000 MAQUET CARDIOVASCULAR LLC Electrode arrangement for use in a medical instrument
6673090, Aug 04 1999 Boston Scientific Scimed, Inc Percutaneous catheter and guidewire for filtering during ablation of myocardial or vascular tissue
6676656, Sep 09 1994 CARDIOFOCUS, INC Surgical ablation with radiant energy
6701176, Nov 04 1998 Johns Hopkins University School of Medicine Magnetic-resonance-guided imaging, electrophysiology, and ablation
6702835, Sep 07 2001 PROMED, INC Needle apparatus for closing septal defects and methods for using such apparatus
6709432, Apr 26 2002 Medtronic, Inc Ablation methods and medical apparatus using same
6712804, Sep 20 1999 Boston Scientific Scimed, Inc Method of closing an opening in a wall of the heart
6712815, Jan 16 2001 CYTYC Surgical Products Apparatus and method for treating venous reflux
6712836, May 13 1999 ST JUDE MEDICAL ATG, INC Apparatus and methods for closing septal defects and occluding blood flow
6723092, Dec 15 2000 BROWN, TONY R Atrial fibrillation RF treatment device and method
6730081, Oct 18 1991 Endoscopic surgical instrument
6735532, Sep 30 1998 L. Vad Technology, Inc. Cardiovascular support control system
6743184, Nov 10 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated System and method for detecting perforations in a body cavity
6743197, Jul 10 1996 Novasys Medical, Inc. Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems
6755822, Jun 01 2001 CRYOCOR, INC Device and method for the creation of a circumferential cryogenic lesion in a pulmonary vein
6764486, Apr 24 2002 BIOTRONIK MESS-UND THERAPIEGERAETE GMBH & CO Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart
6770070, Mar 17 2000 AngioDynamics, Inc Lung treatment apparatus and method
6776780, Jul 18 1997 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
6780183, Sep 16 2002 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
6796981, Sep 30 1999 TYCO HEALTHCARE GROUP AG; Covidien AG Vessel sealing system
6802843, Sep 13 2001 Ethicon Endo-Surgery, Inc Electrosurgical working end with resistive gradient electrodes
6805130, Jun 02 1998 Arthrocare Corporation Methods for electrosurgical tendon vascularization
6813520, Apr 12 1996 CYTYC SURGICAL PRODUCTS, LLC; CYTEC SURGICAL PRODUCTS, LLC Method for ablating and/or coagulating tissue using moisture transport
6821273, Jan 03 2002 Microline Surgical, Inc Combined dissecting, cauterizing, and stapling device
6913579, May 01 2001 Ethicon Endo-Surgery, Inc Electrosurgical working end and method for obtaining tissue samples for biopsy
6939348, Mar 27 2003 Terumo Kabushiki Kaisha Energy based devices and methods for treatment of patent foramen ovale
7165552, Mar 27 2003 Terumo Kabushiki Kaisha Methods and apparatus for treatment of patent foramen ovale
20010014800,
20010034537,
20010037129,
20010039435,
20010041914,
20010041915,
20010049492,
20020010481,
20020026094,
20020029048,
20020032462,
20020035374,
20020052572,
20020096183,
20020111645,
20020111647,
20020129819,
20020183786,
20020183787,
20030028213,
20030045893,
20030045901,
20030050665,
20030069575,
20030073979,
20030088242,
20030100920,
20030109778,
20030139819,
20030144694,
20030181945,
20030191495,
20030191526,
20030195530,
20030195531,
20030204203,
20030208232,
20040044361,
20040049207,
20040092973,
20040143277,
20040143291,
20040143293,
20040143294,
20040193147,
20040193239,
20040215187,
20040220596,
20040220610,
20040230185,
20040243122,
20040254572,
20040267191,
20040267306,
20050021016,
20050034735,
20050070887,
20050080406,
20050125032,
20050131401,
20050131460,
20060027241,
20060074410,
20060241581,
20060241582,
20060241583,
20060241584,
20060247612,
20060271030,
20060271040,
20060271089,
20060276779,
20060276846,
20070010806,
EP317067,
EP553259,
EP750905,
EP1013227,
EP1046375,
EP1222897,
GB2407985,
WO2005115231,
WO18331,
WO27292,
WO74555,
WO121247,
WO130266,
WO130267,
WO130268,
WO149185,
WO217809,
WO224106,
WO3022159,
WO3026525,
WO3059152,
WO3061481,
WO3073944,
WO3077733,
WO2004086944,
WO2004086951,
WO2005070316,
WO2005070491,
WO9513111,
WO9625179,
WO9629946,
WO9631157,
WO9728744,
WO9839063,
WO9905977,
WO9918862,
WO9918864,
WO9918870,
WO9918871,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 06 2006W.L. Gore & Associates, Inc.(assignment on the face of the patent)
Sep 26 2006FORDE, SEANNMT MEDICAL, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0183840456 pdf
Jun 16 2011NMT MEDICAL, INC BY AND THROUGH JOSEPH F FINN, JR , AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF NMT MEDICAL, INC W L GORE & ASSOCIATES, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0265030273 pdf
Date Maintenance Fee Events
Jul 22 2019M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Jul 20 2023M1552: Payment of Maintenance Fee, 8th Year, Large Entity.


Date Maintenance Schedule
Feb 16 20194 years fee payment window open
Aug 16 20196 months grace period start (w surcharge)
Feb 16 2020patent expiry (for year 4)
Feb 16 20222 years to revive unintentionally abandoned end. (for year 4)
Feb 16 20238 years fee payment window open
Aug 16 20236 months grace period start (w surcharge)
Feb 16 2024patent expiry (for year 8)
Feb 16 20262 years to revive unintentionally abandoned end. (for year 8)
Feb 16 202712 years fee payment window open
Aug 16 20276 months grace period start (w surcharge)
Feb 16 2028patent expiry (for year 12)
Feb 16 20302 years to revive unintentionally abandoned end. (for year 12)